Milne Jill C. Insider Trades

Insider Trading History

Track insider trading activity for Milne Jill C.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $130k 15,382 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.62k 528 shares
$8.75
$8.47
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $226k 26,684 shares
Last Trade
Jan 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$282k 41,538 shares
$6.79
$8.47
Astria Therapeutics
Astria Therapeutics ATXS
CEO And President
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$12.1M 960,377 shares
$12.58
$12.58
Astria Therapeutics
Astria Therapeutics ATXS
CEO And President
Holding Value $9.57M 761,000 shares
Last Trade
Mar 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.88M 761,000 shares
$6.41
$12.58
Astria Therapeutics
Astria Therapeutics ATXS
CEO And President
Holding Value $6.73M 534,600 shares
Last Trade
Feb 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.16M 534,600 shares
$15.26
$12.58
Astria Therapeutics
Astria Therapeutics ATXS
CEO And President
Holding Value $3.46M 275,000 shares
Last Trade
Jun 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.12M 275,000 shares
$11.35
$12.58
Astria Therapeutics
Astria Therapeutics ATXS
CEO And President
Holding Value $2.45M 195,000 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 195,000 shares
$6.51
$12.58
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals CATB
CEO And President
Holding Value $12M 1,400,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.1M 1,400,000 shares
$12.24
$8.54
Astria Therapeutics
Astria Therapeutics ATXS
CEO And President
Holding Value $17.6M 1,400,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Astria Therapeutics
Astria Therapeutics ATXS
CEO And President
Holding Value $1.89M 150,000 shares
Last Trade
Feb 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals CATB
CEO And President
Holding Value $1.28M 150,000 shares
Last Trade
Feb 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.79M 150,000 shares
$31.92
$8.54
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals CATB
CEO And President
Holding Value $854k 100,000 shares
Last Trade
Feb 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.63M 100,000 shares
$26.34
$8.54
Astria Therapeutics
Astria Therapeutics ATXS
CEO And President
Holding Value $1.26M 100,000 shares
Last Trade
Feb 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals CATB
CEO And President
Holding Value $1.96M 230,000 shares
Last Trade
Sep 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.76M 230,000 shares
$42.44
$8.54
Astria Therapeutics
Astria Therapeutics ATXS
CEO And President
Holding Value $2.89M 230,000 shares
Last Trade
Sep 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals CATB
CEO And President
Holding Value $1.96M 230,000 shares
Last Trade
Feb 08, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.7M 230,000 shares
$76.80
$8.54
Astria Therapeutics
Astria Therapeutics ATXS
CEO And President
Holding Value $2.89M 230,000 shares
Last Trade
Feb 08, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals CATB
CEO And President
Holding Value $1.71M 200,000 shares
Last Trade
Feb 09, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.8M 200,000 shares
$73.80
$8.54
Astria Therapeutics
Astria Therapeutics ATXS
CEO And President
Holding Value $2.52M 200,000 shares
Last Trade
Feb 09, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals CATB
CEO And President
Holding Value $384k 45,000 shares
Last Trade
Sep 08, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.6M 45,000 shares
$258.42
$8.54

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up